Digestive Enzyme Syp,Dexorange oblique Iron syp,Grilintus Syp,Lactulose syp each 5ml containing 3.3
Indian Army
Progress
Quantity
79349
Indian Army announces a tender for Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray, isoflurane bottle of 250 ml, RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm, Pegylated GCSF 6 mg Inj, HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN, HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN, NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE, Menotrophin 5U FSH 75 ULH Inj, USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML, Inj Posaconazole 300 mg, THIOTEPA 15 MG INJ in PUNE, MAHARASHTRA. Quantity: 79349. Submission Deadline: 03-06-2025 16: 00: 00. Last date to apply is approaching fast!
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
Dg Armed Forces Medical Service
DARJEELING, WEST BENGAL
Indian Army
Indian Army
JALANDHAR, PUNJAB
Indian Navy
MUMBAI, MAHARASHTRA
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray | Diclofenac diethylamine 2 32 percent wv quick petrating topical solution 30 ml bottle with metered dose spray | 1,330 | 1330 | gemdglp@2024 | 30 |
| 2 | isoflurane bottle of 250 ml | isoflurane bottle of 250 ml | 900 | 900 | gemdglp@2024 | 30 |
| 3 | RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm | RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL 150 tube of 15 gm | 150 | 150 | gemdglp@2024 | 30 |
| 4 | Pegylated GCSF 6 mg Inj | Pegylated GCSF 6 mg Inj | 360 | 360 | gemdglp@2024 | 30 |
| 5 | HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | HUMAN INSULIN ANALOGUE GLARGINE INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | 5,900 | 5900 | gemdglp@2024 | 30 |
| 6 | HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | HUMAN INSULIN ANALOGUE RAPID ACTING INJ 100 IU ML RECOMBINANT DNA ORIGIN 300 IU DISPOSABLE PEN WITH 5 NEEDLES PER PEN | 7,600 | 7600 | gemdglp@2024 | 30 |
| 7 | NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE | NATURAL MICRONISED PROGESTERONE 200 MG SOFT GELATIN CAPSULE | 60,000 | 60000 | gemdglp@2024 | 30 |
| 8 | Menotrophin 5U FSH 75 ULH Inj | Menotrophin 5U FSH 75 ULH Inj | 3,000 | 3000 | gemdglp@2024 | 30 |
| 9 | USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML | USTEKINUMAB SOLUTION FOR SUBCUTANEOUS STELARA 90 MG 1 ML | 12 | 12 | gemdglp@2024 | 30 |
| 10 | Inj Posaconazole 300 mg | Inj Posaconazole 300 mg | 72 | 72 | gemdglp@2024 | 30 |
| 11 | THIOTEPA 15 MG INJ | THIOTEPA 15 MG INJ | 25 | 25 | gemdglp@2024 | 30 |
Discover companies most likely to bid on this tender
Key insights about MAHARASHTRA tender market
The eligibility requirements include being a registered entity capable of supplying pharmaceutical products, compliance with regulatory standards, and demonstrating a successful history in similar deliveries. It is essential for bidders to provide documentation proving their capabilities, including certifications and proof of past deliveries.
Bidders must adhere to specified technical specifications that ensure the isoflurane meets pharmacopoeial quality standards. The product must demonstrate efficacy, safety, and regulatory compliance, supported by proper documentation such as quality assurance certifications.
While participating in this tender, an Earnest Money Deposit (EMD) may be required to secure the bid. Bidders should check the specific tender requirements for details on the deposit amount and acceptable forms. The EMD acts as a security measure, reinforcing commitment to fulfill the contract upon winning the bid.
The evaluation and selection process will be transparent, focusing on the submitted documents' technical and financial aspects. Bidders will be rated based on their compliance with the tender requirements, pricing, and overall capability to deliver the requested products within the required timeframe.
Yes, there are specific provisions that favor MSEs and startups during the evaluation process. These entities may receive advantages that allow them to compete effectively, encouraging opportunities for smaller businesses to engage in significant contracts and build their capabilities within the defense sector.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS